Skip directly to Accessibility Notice

PPH
VanEck Vectors Pharmaceutical ETF

Fund Description

VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH
  • Exchange

    NASDAQ
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    State Street Bank and Trust Company
  • Index Ticker

    MVPPHTR
  • Index Rebalancing

    Quarterly

 
as of 01/20/21

  • 30-Day SEC Yield1

    1.46%
  • Total Net Assets

    $256.0M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.42%
  • Net Expense Ratio/TER2

    0.36%
  • Distribution Frequency

    Quarterly

Key Points

  • Highly Liquid Companies 
    Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume

  • Industry Leaders
    Index methodology favors the largest companies in the industry

  • Global Scope 
    Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Trading Information

  • Fund Ticker

    PPH
  • Index Total Return Ticker

    MVPPHTR
  • NAV

    PPHNV
  • Intraday NAV (IIV)4

    PPHIV
  • Shares Outstanding

    3,638,138
  • Estimated Cash

    PPHEU
  • Total Cash

    PPHTC
  • CUSIP

    92189F692
  • ISIN

    US92189F6925
Source: Bloomberg

Fees and Expenses2

  • Management Fee

    0.35%
  • Other Expenses

    0.07%
  • Gross Expense Ratio

    0.42%
  • Fee Waivers and
    Expense Reimbursement

    -0.06%
  • Net Expense Ratio/TER2

    0.36%
2Expenses for PPH are capped contractually at 0.35% until February 1, 2021. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Prices as of 01/20/21

NAV/
Market Price
Volume
30-Day Avg./
Last Trading Day
Daily Change
NAV/
Last Price
YTD Change
NAV/
Last Price
Premium/
Discount
Prem/Discount
Distribution Charts
NAV &
Prem/Discount
History
30-Day
Median
Bid Ask
Spread
NAV
Chart
PPH $70.36
$70.33
47,085
115,201
-$0.22 / -0.31%
$-0.25 / -0.35%
+6.31%
+6.21%
$-0.03
-0.04%
0.05%

Premium/Discount History as of 01/20/21

Calendar Year 2019 1Q 2020 2Q 2020 3Q 2020 4Q 2020 Premium/Discount Charts NAV & Prem/Discount History
Days closed at a premium 88 22 32 29 41
PPH Days closed at NAV 22 5 3 8 1
Days closed at a discount 142 35 28 27 22

Performance History: Average Annual Total Returns* (%)

1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 2.15 7.47 5.20 5.20 5.74 2.33 -- 9.26
PPH (Share Price) 2.20 7.35 5.33 5.33 5.77 2.32 -- 9.38
MVPPHTR (Index) 2.49 7.80 4.96 4.96 5.60 2.26 -- 9.22
Performance Differential (NAV - Index) -0.34 -0.33 0.24 0.24 0.14 0.07 -- 0.04
1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 2.15 7.47 5.20 5.20 5.74 2.33 -- 9.26
PPH (Share Price) 2.20 7.35 5.33 5.33 5.77 2.32 -- 9.38
MVPPHTR (Index) 2.49 7.80 4.96 4.96 5.60 2.26 -- 9.22
Performance Differential (NAV - Index) -0.34 -0.33 0.24 0.24 0.14 0.07 -- 0.04

Top 10 Holdings (%) as of 12/31/20 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
ELI LILLY AND CO
LLY US
79,707
13,457,730 5.35
NOVARTIS AG
NVS US
137,473
12,981,575 5.16
JOHNSON & JOHNSON
JNJ US
82,262
12,946,394 5.14
BRISTOL-MYERS SQUIBB CO
BMY US
206,730
12,823,462 5.09
CATALENT INC
CTLT US
122,789
12,778,651 5.08
NOVO NORDISK A/S
NVO US
179,276
12,522,429 4.98
ABBVIE INC
ABBV US
115,892
12,417,828 4.93
MERCK & CO INC
MRK US
150,882
12,342,148 4.90
SANOFI
SNY US
253,861
12,335,106 4.90
VIATRIS INC
VTRS US
646,953
12,123,899 4.82
Top 10 Total (%) 50.35
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 12/31/20

  • Country

    % of Net Assets
  • United States

    65.63
  • United Kingdom

    9.98
  • Switzerland

    5.16
  • Denmark

    4.98
  • France

    4.90
  • Japan

    4.39
  • Israel

    4.08
  • Ireland

    0.93
  • Other/Cash

    -0.04

Sector Weightings (%) as of 12/31/20

  • Sector

    % of Net Assets
  • Health Care

    100.0
  • Other/Cash

    0.0